iPSC-derived Regenerative Cell Therapy (XellSmart Biomedical (Suzhou))

N/A

Report date: 2025/06/30 16:21:48

Base Information

Drug NameiPSC-derived Regenerative Cell Therapy (XellSmart Biomedical (Suzhou))
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesXellSmart Bio-Pharmaceutical (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXellSmart Bio-Pharmaceutical (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsSpinal Cord Injuries
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A